IOLCP's stock rallies 10% after securing nod for cholesterol drug
The stock price jump came after the company got China's drug regulatory authority NMPA's nod for cholesterol drug Fenofibrate, allowing the company to export it to the Chinese market IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - National Medical Products Administration (NMPA), China Approves Fenofibrate Manufactured By The Company
NMPA, China approves Fenofibrate manufactured by the Company IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmed of Credit Rating for bank facilities IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Closure of Trading Window
Notice of closure of Trading Window IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Schedule Of Analyst /Institutional Investor Meeting
Schedule of analyst/institutional meeting IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Issue of Letter of Confirmation in lieu of lost share certificate IOL Chemicals share price up 6% on bagging CEP certificate for Pantoprazole
Pantoprazole is used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD) IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Company Received CEP Certificate For 'Allopurinol'
Company received CEP Certificate for "Allopurinol" IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Company Received CEP Certificate For 'Pantoprazole Sodium Sesquihydrate' For Alternative Process (Process - II)
Company received CEP Certificate for "Pantoprazole Sodium Sesquihydrate" for alternative process (Process - II)